Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I crossover study of DRL-21994 versus Niaspan in healthy male volunteers
NL-OMON33352Phase 1Withdrawn
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of niacin in hyperlipidemia, hypercholesterolemia and lipid disorder (2 arms), sponsored by Dr. Reddy's Laboratories. Primary endpoint: Peripheral vasodilation. Planned start Jul 2009; status: withdrawn.
02
Drugs
niacin
03
Conditions
hyperlipidemiahypercholesterolemialipid disorder
Beyond the preview
Go deeper on NL-OMON33352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33352.